World Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Wellness Times.

Press releases published on November 9, 2026

Fertilizer, Weed Control, or a Lawn Program? Superior Lawn Care Explains What Your Lawn Actually Needs
Costway Announces Black Friday 2026 Sale Featuring Three Promotional Stages and Coupons
DALTEX, One of the World’s Largest Fresh Potato Exporters, Deploys AI at Scale with ORTH
Solana Company to Release Third Quarter 2026 Operating Results on November 11, 2026
U.S. Postal Service Announces Stamp Subjects for 2027
Zealand Pharma to participate in the Jefferies Global Healthcare Conference
Kyverna Therapeutics Announces Publication of Registrational Miv-cel Data in Patients with Stiff Person Syndrome in JAMA Neurology
Stanford Medicine Sutter Health Cancer Center expands access to advanced cancer care in the East Bay
Hinge Bio Shares Encouraging Clinical Data for HB2198, a Novel B-Cell Depleting Agent for Treating Autoimmune Disease, at ACR Convergence 2026
Baylor Genetics to Highlight the Clinical Value of Genomics in Pediatric Care at the 2026 National Society of Genetic Counselors Annual Meeting
Cullinan Therapeutics to Participate in Upcoming Investor Conferences
Kraig Labs Ships Spider Silk to Developers Across Global Industries
Boehringer Ingelheim's survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase III SYNCHRONIZE-CVOT trial alongside significant cardiometabolic benefits
Zealand Pharma announces Boehringer Ingelheim’s survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase 3 SYNCHRONIZE-CVOT trial with significant cardiometabolic benefits
Oncovita Granted Orphan Drug Designation For MVdeltaC in Mesothelioma by the European Commission
Pelareorep Induces Coordinated Antiviral Immune Responses and Enhanced Antitumor Immunity in Multiple Myeloma Patients
USARAD, a Nanox Company, Expands Collaboration with AZmed to Integrate FDA-Cleared X-ray AI into Its Teleradiology Workflows
CRISPR Therapeutics Presents Phase 1b Data for CTX310® Demonstrating Reductions in ANGPTL3 and Triglycerides in Patients with Severe Hypertriglyceridemia at the American Heart Association (AHA) Scientific Sessions 2026
Park Dental Partners Completes Acquisition of Village Family Dental Support Services Organization, Expands into North Carolina
Presidio and F5 Create a Reusable Trust Foundation for Financial Services AI

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

World Wellness Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.